TipRanks
TipRanksTop Financial ExpertsInsidersKathleen Sebelius

Kathleen Sebelius Insider Profile

4 Followers
Kathleen Sebelius, Director at Humacyte, holds 148.03K shares in Humacyte (Ticker: HUMA), holds 6.00K shares in Journey Medical Corp (Ticker: DERM), holds 6.00K shares in Dermira (Ticker: ~DERM). Most recently, Kathleen Sebelius Bought ― shares of Humacyte on May 20, 2026 for an estimated value of $50.00K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Kathleen Sebelius

Kathleen Sebelius
Humacyte (HUMA)
Director

Ranked #22,444 out of 109,030 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+22.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$126K
64.87%
35.13%
A breakdown of Kathleen Sebelius's holdings
See the Top Stocks by Insiders

Insider Roles

Humacyte
(HUMA)
Director
Journey Medical Corp
(DERM)
Director
Roles that Kathleen Sebelius holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Myovant Sciences
(MYOV)
Rating:Informative Buy
Date:Jun 14, 2019 - Jun 14, 2020
Return:+93.50%
The most profitable trade made by Kathleen Sebelius
See the Latest Stocks Traded by Insiders

Kathleen Sebelius's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HUMA
Humacyte
May 20, 2026
Director
Informative Buy
50.00K
$81.56K
DERM
Journey Medical Corp
―
Director
―
$44.16K
~DERM
Dermira
―
―
―
$112.50K
MYOV
Myovant Sciences
Jun 14, 2019
―
Informative Buy
44.78K
$134.90K
EXAS
Exact Sciences
Jun 17, 2024
―
Uninformative Buy
―
$3.35M
List of latest transactions for each holding click on a transaction to see Kathleen Sebelius's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Kathleen Sebelius insider profile FAQ

What is the percentage of profitable transactions made by Kathleen Sebelius?
The percentage of profitable transactions made by Kathleen Sebelius is 50%.
    What is the average return per transaction made by Kathleen Sebelius?
    The average return per transaction made by Kathleen Sebelius is 22.90%.
      What stocks does Kathleen Sebelius hold?
      Kathleen Sebelius holds: HUMA, DERM, ~DERM, MYOV, EXAS stocks.
        What was Kathleen Sebelius’s latest transaction?
        Kathleen Sebelius latest transaction was an Informative Buy of $50.00K.
          What was Kathleen Sebelius's most profitable transaction?
          Kathleen Sebelius’s most profitable transaction was an Informative Buy of MYOV stock on June 14, 2019. The return on the trade was 93.50%.
            What is Kathleen Sebelius's role in Humacyte?
            Kathleen Sebelius's role in Humacyte is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.